Literature DB >> 13925282

Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate.

S VELU, R H ANDREWS, J H ANGEL, S DEVADATTA, W FOX, P R GANGADHARAM, A S NARAYANA, C V RAMAKRISHNAN, J B SELKON, P R SOMASUNDARAM.   

Abstract

This study from the Tuberculosis Chemotherapy Centre, Madras, summarizes the progress during the second year of those patients in a 1-year comparison of four domiciliary chemotherapeutic regimens (isoniazid plus PAS and three regimens of isoniazid alone) whose pulmonary tuberculosis had attained bacteriological quiescence at the end of the year of chemotherapy. During the second year, about half of the patients received further chemotherapy, with isoniazid alone, and the remainder received a placebo, calcium gluconate. The main objects of the study were to determine the influence on the progress during the second year of (a) a second year of chemotherapy with isoniazid alone, (b) residual cavitation at the end of the first year, and (c) the chemotherapeutic regimen received during the first year, and to compare the results with those obtained in an earlier study by the Centre of the progress during the second year of patients with quiescent pulmonary tuberculosis after a year's chemotherapy with isoniazid plus PAS at home or in sanatorium.The results of the present study, which was planned on the same lines as the earlier one, showed that relapse in the second year was unrelated to the chemotherapeutic regimen received in the first year, and it was therefore permissible to amalgamate the findings in the two studies. The amalgamated results showed that the relapse rate in the second year was low (5.9%) and that a second year of treatment with isoniazid alone was of definite value for the patients with no residual cavitation at the end of the first year, but had no effect on the relapse rate of those with residual cavitation. The combined data from the two studies have thus clarified the position with regard to the effectiveness of isoniazid in preventing bacteriological relapse in patients without residual cavitation, slight evidence of which was apparent in the earlier study.

Entities:  

Keywords:  ISONIAZID/therapy; PARA-AMINOSALICYLIC ACID/therapy

Mesh:

Substances:

Year:  1961        PMID: 13925282      PMCID: PMC2555578     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

Authors:  S VELU; R H ANDREWS; S DEVADATTA; W FOX; S RADHAKRISHNA; C V RAMAKRISHNAN; J B SELKON; P R SOMASUNDARAM; T V SUBBAIAH
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

2.  [The detection of isoniazid in urine].

Authors:  P R GANGADHARAM; D A MITCHISON; T V SUBBAIAH; E I SHORT
Journal:  Tubercle       Date:  1958-08

3.  The late results of prolonged multiple-drug therapy for pulmonary tuberculosis.

Authors:  J W RALEIGH
Journal:  Am Rev Tuberc       Date:  1957-10

4.  A schema for tuberculosis revisted.

Authors:  W B TUCKER
Journal:  Am Rev Tuberc       Date:  1958-09

5.  The treatment of pulmonary tuberculosis with prolonged streptomycin, sodium P-aminosalicylate and isoniazid.

Authors:  J SMART; J GOUGH
Journal:  Br J Tuberc Dis Chest       Date:  1958-07

6.  Hospital treatment of pulmonary tuberculosis; a follow-up study of patients admitted to Edinburgh hospitals in 1953.

Authors:  J D ROSS; N W HORNE; I W GRANT; J W CROFTON
Journal:  Br Med J       Date:  1958-02-01

7.  Indefinitely prolonged chemotherapy for tuberculosis; an appeal.

Authors:  A S DOONEIEF; K E HITE; R G BLOCH
Journal:  AMA Arch Intern Med       Date:  1955-10

8.  Peripheral neuritis due to isoniazid.

Authors:  S DEVADATTA; P R GANGADHARAM; R H ANDREWS; W FOX; C V RAMAKRISHNAN; J B SELKON; S VELU
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

9.  Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

Authors:  S DEVADATTA; R H ANDREWS; J H ANGEL; A L BHATIA; W FOX; B JANARDHANAM; S RADHAKRISHNA; C V RAMAKRISHNAN; T V SUBBAIAH; S VELU
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

  9 in total
  14 in total

1.  Chapter 4. Public health benefits.

Authors: 
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

2.  The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS.

Authors:  C V RAMAKRISHNAN; A L BHATIA; S DEVADATTA; W FOX; A S NARAYANA; J B SELKON; S VELU
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

3.  A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 2. Second report: the results from 12 to 24 months.

Authors: 
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis.

Authors: 
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

5.  Comparative value of sputum smear examination and culture examination in assessing the progress of tuberculous patients receiving chemotherapy.

Authors:  S Devadatta; S Radhakrishna; W Fox; D A Mitchison; S Rajagopalan; S Sivasubramanian; H Stott
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

6.  The prevention and treatment of isoniazid toxicity in the therapy of pulmonary tuberculosis: 1. An assessment of two vitamin B preparations and glutamic acid.

Authors: 
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

7.  Isoniazid plus thioacetazone compared with two regimens of isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis in South Indian patients.

Authors: 
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

8.  THE PREVENTION AND TREATMENT OF ISONIAZID TOXICITY IN THE THERAPY OF PULMONARY TUBERCULOSIS. 2. AN ASSESSMENT OF THE PROPHYLACTIC EFFECT OF PYRIDOXINE IN LOW DOSAGE.

Authors:  L A ZILBER; Z L BAJDAKOVA; A N GARDASJAN; N V KONOVALOV; T L BUNINA; E M BARABADZE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

9.  A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS.

Authors:  J J Dawson; S Devadatta; W Fox; S Radhakrishna; C V Ramakrishnan; P R Somasundaram; H Stott; S P Tripathy; S Velu
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

10.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 2. Clinical implications in the treatment of pulmonary tuberculosis with isoniazid either alone or in combination with PAS.

Authors:  J B SELKON; W FOX; P R GANGADHARAM; K RAMACHANDRAN; C V RAMAKRISHNAN; S VELU
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.